Rixheim, France

Olivier Lohse

USPTO Granted Patents = 5 



Average Co-Inventor Count = 2.9

ph-index = 2

Forward Citations = 10(Granted Patents)


Location History:

  • Belfort, FR (2005)
  • Rixheim, FR (2006 - 2012)

Company Filing History:


Years Active: 2005-2012

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Olivier Lohse: Innovator in Pharmaceutical Chemistry

Introduction

Olivier Lohse is a notable inventor based in Rixheim, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on quinolinone derivatives. With a total of 5 patents to his name, Lohse has demonstrated a commitment to advancing medical science.

Latest Patents

Lohse's latest patents include groundbreaking work on quinolinone derivatives and their pharmaceutical compositions. One of his notable inventions involves compounds of formula I in salt or solvate form, which are useful for treating diseases mediated by the β-adrenoreceptor. Additionally, he has developed a process for preparing 5-(halocetyl)-8-(substituted oxy)-(1H)-quinolin-2-ones, which outlines a detailed method for synthesizing these compounds through various chemical reactions.

Career Highlights

Throughout his career, Olivier Lohse has worked with prominent companies in the pharmaceutical industry, including Novartis AG and Novartis Pharma GmbH. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in drug development.

Collaborations

Lohse has collaborated with esteemed colleagues such as Mahavir Prashad and Bin Hu. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Olivier Lohse's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a key innovator in the field. His work continues to impact the development of new treatments and therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…